Applied Pharmacology for the Dental Hygienist 9th Edition, Elena Bablenis Havles, dental pharmacology test bank, verified dental exam answers,

Applied Pharmacology for The Dental Hygienist 9th E
9 9 9 9 9 9 9


dition by Elena Bablenis Haveles
9 9 9 9




Complete Test Bank
9 9

,Chapter901:9Information9Sources,9Regulatory9Agencies,9Drug9Legislation,9and9Prescription9Wr
iting
Haveles:9Applied9Pharmacology9for9the9Dental9Hygienist,99th9Edition



MULTIPLE9CHOICE

1. Knowledge9of9pharmacology9aids9the9dental9professional9in
a. obtaining9a9patient’s9health9history.
b. administering9drugs9in9the9office.
c. handling9emergency9situations.
d. selection9of9a9nonprescription9medication.
e. All9of9the9above.
ANS:9 E
All9of9the9choices9are9true.9Because9many9of9our9patients9are9being9treated9with9drugs,9knowledge9of
9pharmacology9helps9in9understanding9and9interpreting9patients’9responses9to9health9history9questions
.9Knowledge9of9the9therapeutic9and9adverse9effects9of9medications9obviously9helps9in9their9proper9ad
ministration9in9the9office.9Emergency9situations9may9be9caused9by9drugs9or9treated9by9drugs;9thus,9k
nowledge9of9pharmacology9is9of9great9help,9especially9because9a9rapid9response9is9sometimes9requir
ed.9A9clear9understanding9of9the9concepts9of9drug9action,9drug9handling9by9the9body,9and9drug9intera
ctions9will9allow9the9dental9practitioner9to9make9proper9judgments9and9grasp9the9concepts9relevant9to
9new9drug9therapies9on9the9market.


DIF: Application
REF:9 Role9of9the9Dental9Hygienist9(Medication/Health9History),9Role9of9the9Dental9Hygienist9(Medicati
on9Administration),9Role9of9the9Dental9Hygienist9(Emergency9Situations),9Role9of9the9Dental9Hygienist9(
Nonprescription9Medication)9|9pp.92-3 OBJ: 1
TOP:9 NBDHE,96.0.9Pharmacology

2. Which9of9the9following9statements9is9true9regarding9planning9appointments?
a. Whether9or9not9patients9are9taking9medication9for9systemic9diseases9is9of9littl
e
consequence9in9the9dental9office.
b. Asthmatic9patients9should9have9dental9appointments9in9the9morning.
c. Diabetic9patients9usually9have9fewer9problems9with9a9morning9appointment 9c
ompared9with9afternoon9appointments.
d. Both9B9and9C9are9true.
ANS:9 D
Asthmatic9patients9who9experience9dental9anxiety9should9schedule9their9appointments9when9they9are9
not9rushed9or9under9pressure9early9in9the9morning.9Diabetic9patients9usually9have9relatively9fewer9pr
oblems9with9a9morning9appointment.9Patients9taking9medication9for9systemic9diseases9may9require9s
pecial9handling9in9the9dental9office.

DIF: Comprehension
REF:9 Role9of9the9Dental9Hygienist9(Appointment9Scheduling)9|9p.9
39OBJ:9 1 TOP:9 NBDHE,96.0.9Pharmacology

,3. Nutritional9or9herbal9supplements
a. carry9the9U.S.9Food9and9Drug9Administration9(FDA)9approval9for9disease9states
.
b. are9not9drugs.
c. can9cause9adverse9effects.
d. will9not9interact9with9other9drugs9the9patient9may9be9taking.
ANS:9 C
Nutritional9or9herbal9supplements9are9quite9capable9of9causing9adverse9effects.9The9majority9of9nutritio
nal9or9herbal9supplements9do9not9carry9FDA9approval9for9treating9disease9states.9These9supplements9ar
e9drugs9and9can9cause9adverse9effects9and9interact9with9different9drugs.

DIF: Comprehension
REF:9 Role9of9the9Dental9Hygienist9(Nutritional9or9Herbal9Supplements)9|9p.
939OBJ:9 1 TOP:9 NBDHE,96.0.9Pharmacology

4. Which9type9of9drug9name9usually9begins9with9a9lowercase9letter?
a. Brand9name
b. Code9name
c. Generic9name
d. Trade9name
ANS:9 C
Before9any9drug9is9marketed,9it9is9given9a9generic9name9that9becomes9the9“official”9name9of9the9drug
.9Each9drug9is9assigned9only9one9generic9name9selected9by9the9U.S.9Adopted9Name9Council,9and9the
9name9is9not9capitalized.9The9brand 9name9is9equivalent9to9the9trade9name9and9is9capitalized.9Althoug
h9the9brand9name9is9technically9the9name9of9the9company9marketing9the9product,9this9term9is9often9us
ed9interchangeably9with9the9trade9name.9The9code9name9is9the9initial9term9used9within9a9pharmaceuti
cal9company9to9refer9to9a9drug9while9it9is9undergoing9investigation9and9is9often9a9combination9of9cap
ital9letters9and9numbers,9the9letters9representing9an9abbreviation9of9the9company9name.

DIF: Comprehension
REF:9 Drug9Names9|9p.949OBJ:9 3
TOP:9 NBDHE,96.0.9Pharmacology

5. A9drug’s9generic9name9is9selected9by9the
a. pharmaceutical9company9manufacturing9it.
b. Food9and9Drug9Administration9(FDA).
c. U.S.9Adopted9Name9Council.
d. Federal9Patent9Office.
ANS:9 C
Each9drug9is9assigned9only9one9generic9name9(e.g.,9ibuprofen).9It9is9selected9by9the9U.S.9Adopted9Na
me9Council.9The9generic9name9is9not9selected9by9the9FDA9or9the9Federal9Patent9Office.9The9pharma
ceutical9company9manufacturing9the9drug9clearly9has9an9influence9on9the9generic9name9given9its9dru
g,9but9the9final9decision9is9not9the9company’s.

DIF: Recall REF:9 Drug9Names9|9p.94
OBJ:9 39TOP:9 NBDHE,96.0.9Pharmacology

6. Which9of9the9following9is9true9concerning9generic9and9trade9names9of9drugs?
a. A9drug9may9only9have9one9generic9name9and9one9trade9name
.

, b. A9drug9may9only9have9one9generic9name,9but9it9may9have9several9trade9name
s.
c. A9drug9may9have9several9generic9names,9but9it9may9only9have9one9trade9nam
e.
d. A9drug9may9have9several9generic9names9and9several9trade9names.
ANS:9 B
Each9drug9has9only9one9generic9name9but9may9have9several9trade9names.9For9each9drug,9there9is9only
9one9generic9name.9It9is9not9capitalized,9and9it9becomes9the9“official”9name9of9the9drug.9The9pharmac
eutical9company9discovering9the9drug9gives9the9drug9a9trade9name.9The9trade9name9is9protected9by9th
e9Federal9Patent9Law9for9209years9from9the9earliest9claimed9filing9date,9plus9patent9term9extensions.9
Although9the9brand9name9is9technically9the9name9of9the9company9marketing9the9product,9it9is9often9u
sed9interchangeably9with9the9trade9name.

DIF: Comprehension
REF:9 Drug9Names9|9p.949OBJ:9 3
TOP:9 NBDHE,96.0.9Pharmacology

7. Two9drugs9that9are9found9to9be9chemically9equivalent,9but9not9biologically9equivalent9
or9therapeutically9equivalent9are9said9to9differ9in
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic9index.
ANS:9 C
A9preparation9can9be9chemically9equivalent9yet9not9biologically9or9therapeutically9equivalent.9These9
products9are9said9to9differ9in9their9bioavailability.9The9potency9of9a9drug9is9a9function9of9the9amount9
of9drug9required9to9produce9an9effect.9The9efficacy9is9the9maximum9intensity9of9effect9or9response9th
at9can9be9produced9by9a9drug.9The9therapeutic9index9is9the9ratio9of9the9lethal9dose9for950%9of9the9ex
perimental9animals9divided9by9the9effective9dose9for950%9of9the9experimental9animals.9If9the9value9o
f9the9therapeutic9index9is9small,9toxicity9is9more9likely.

DIF: Recall
REF:9 Drug9Names9(Drug9Substitution)9|9p.959OBJ:9 4
TOP:9 NBDHE,96.0.9Pharmacology

8. How9many9years9must9pass9after9a9drug9patent9expires9before9other9drug9companies9can9market9t
he9same9compound9as9a9generic9drug?
a. 209years
b. 179years
c. 79years
d. 09years
ANS:9 D
Once9a9drug9patent9expires,9competing9companies9may9immediately9market9the9same9compound9in9g
eneric9form.9The9pharmaceutical9company9discovering9the9drug9gives9the9drug9a9trade9name.9The9tra
de9name9is9protected9by9the9Federal9Patent9Law9for9209years9from9the9earliest9claimed9filing9date,9pl
us9the9patent9term9extensions.

DIF: Application
REF:9 Drug9Names9(Drug9Substitution)9|9p.959OBJ:9 4
TOP:9 NBDHE,96.0.9Pharmacology